Here's why these 4 ASX shares are getting crushed today

The S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) might be rallying today but here are four shares that are getting crushed.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Following the US Federal Reserve's decision to keep US interest rates on hold and an overnight rally in commodity prices, the S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) is enjoying a solid day of gains with the main index rallying 1.2%.

Not all shares are taking part in today's rally, however, and these four companies are deep in the red:

ResMed Inc. (CHESS) (ASX: RMD)

ResMed shares have lost more than 4% today despite the absence of any specific company news being released. It appears investors may be concerned about the impact of the recent surge in the Australian dollar which will negatively impact the value of its ASX scrip. Investors may also be weary of further competition in the sector with the likes of Somnomed Limited (ASX: SOM) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) both delivering healthy growth in their most recent earnings results.

Magellan Financial Group Ltd (ASX: MFG)

Shares of Magellan are down by more than 2.2% today as investors digest the potential negative impact on its earnings from a higher Australian dollar. Despite this, Magellan still looks like a good long-term winner thanks to its superior track record of delivering out-performance and strong relationships with institutional investors.

Ramsay Health Care Limited (ASX:RHC)

The shares of the private hospital operator have been under pressure over the past seven trading days and today's 1% fall takes its seven-day loss to more than 8%. Ramsay is the market leader in France and it appears most of the recent share price decline can be attributed to the French Government's decision to cut its tariffs for private hospitals by more than anticipated. Despite this, the company has assured investors this would not impact the company's earnings guidance which was recently upgraded following the release of its first half earnings in February.

Retail Food Group Limited (ASX: RFG)

Shares of Retail Food Group started the day on the back foot and at one point had fallen more than 5.6%. The shares have since stabilised but were still trading down by more than 4.5% at the time of writing. The obvious reason for the fall is that the shares are trading ex-dividend today. The company will pay investors a fully-franked dividend of 13 cents a share – an increase of 13% from the previous corresponding period.

Motley Fool contributor Christopher Georges owns shares of Retail Food Group. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia owns shares of Retail Food Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »

Child with superhero mask and cape flies after jumping on sofa
AI Stocks

3 of the fastest-growing stocks on the planet in 2025

These stocks soared in 2025.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Could CSL shares outperform the ASX 200 in 2026?

After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better.

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Healthcare Shares

Why did CSL shares crash 39% in 2025?

Should you be buying the dip? Let's find out.

Read more »